{
    "title": "U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing'",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9061069/U-S-hospital-demand-Lilly-Regeneron-COVID-19-antibody-drugs-disappointing.html",
    "date": "2020-12-16",
    "keywords": [
        "health",
        "antibody",
        "risk",
        "use",
        "covid19",
        "infusion",
        "bamlanivimab",
        "beasley",
        "regeneron",
        "dr",
        "slaoui",
        "emergency",
        "perez",
        "disease",
        "houston",
        "methodist",
        "system",
        "dose",
        "mab",
        "squad",
        "intermountain",
        "dec",
        "eli",
        "co",
        "hospitalization",
        "demand",
        "operation",
        "speed",
        "chief",
        "advisor",
        "moncef",
        "conference",
        "call",
        "government",
        "program",
        "complexity",
        "diagnosis",
        "need",
        "department",
        "human",
        "combination",
        "casirivimab",
        "imdevimab",
        "authorization",
        "age",
        "mabs",
        "shorthand",
        "body",
        "coronavirus",
        "infection",
        "cocktail",
        "president",
        "bit",
        "pharmacist",
        "hospital",
        "day",
        "drug",
        "material",
        "institutes",
        "society",
        "recommend",
        "brandon",
        "physician",
        "healthcare",
        "center",
        "realworld",
        "stratification",
        "tool",
        "highestneed",
        "team",
        "test",
        "treatment",
        "state",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}